主动脉瓣再植入术后20年随访结果
该研究对1989至2012年间在本院接受主动脉瓣再植入术(RAV)的333例主动脉根部动脉瘤患者进行前瞻性随访,平均临床随访10.3±6.8年。结果显示15年和20年生存率分别为77.9±2.9%和72.4±3.8%,15至20年免于中度以上主动脉瓣反流为96.2±1.0%,免于再手术为96.9±1.3%,表明RAV在第二个十年观察期内仍提供优异的临床结果和稳定的主动脉瓣功能。
要点
- RAV术后15年和20年生存率分别为77.9±2.9%和72.4±3.8%。
- 15至20年免于中度以上主动脉瓣反流为96.2±1.0%。
- 15至20年免于主动脉瓣再手术为96.9±1.3%。
核心结论
- RAV在第二个十年观察期内继续提供优异的临床结果和稳定的主动脉瓣功能。
研究设计与样本
- 前瞻性随访研究,纳入1989至2012年间在本院接受RAV的333例主动脉根部动脉瘤患者,平均临床随访10.3±6.8年。
主要发现
- 患者平均年龄46±5岁,男性占78%;马方综合征124例,二叶式主动脉瓣45例,A型主动脉夹层28例,中重度主动脉瓣反流144例。
- 早期死亡(<90天)4例,晚期死亡35例;15年和20年生存率分别为77.9±2.9%和72.4±3.8%。
- 随访期间11例出现中度或重度主动脉瓣反流,采用区间删失法估计15至20年免于该事件率为96.2±1.0%。
- 6例接受主动脉瓣再手术(术后2天至23年),包括1例感染性心内膜炎和5例主动脉瓣反流,15至20年免于再手术率为96.9±1.3%。
临床怎么用
- 对于主动脉根部动脉瘤患者,RAV可作为一种提供稳定远期瓣膜功能的保留主动脉瓣手术选项。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To provide additional information on clinical and echocardiographic outcomes after reimplantation of the aortic valve (RAV) in patients with aortic root aneurysm. METHODS: All 333 patients who underwent RAV at our hospital between 1989 and 2012 were followed prospectively with periodical clinical assessment and echocardiography. The mean duration of clinical follow-up was 10.3 ± 6.8 years, and follow-up was completed within 2 years before this report. RESULTS: The study cohort had a mean patient age was 46 ± 5 years and was 78% male. The aortic root aneurysm was associated with Marfan syndrome in 124 patients, with bicuspid aortic valve in 45, with type A aortic dissection in 28, and with moderate to severe aortic regurgitation (AR) in 144. In addition to the RAV, 113 patients underwent another cardiac procedure owing to associated pathology. There were 4 early deaths (<90 days) and 35 late deaths. Survival at 15 and 20 years was 77.9 ± 2.9% and 72.4 ± 3.8%, respectively. Eleven patients developed moderate or severe AR during the follow-up; using interval censoring, 96.2 ± 1.0% were free from this event at 15 to 20 years. Six patients underwent reoperation on the aortic valve at 2 days to 23 years after RAV, including 1 patient for endocarditis and 5 patients for AR; freedom from reoperation at 15 to 20 years was 96.9 ± 1.3%. Seventeen patients sustained stroke or transient ischemic attacks; 92.5 ± 2.8% were free from thromboembolism at 15 and 20 years. Three patients developed infective endocarditis: 1 in the aortic valve and 2 in the mitral valve. CONCLUSIONS: RAV continues to provide excellent clinical results and stable aortic valve function during the second decade of observation.
引用
- David TE, David CM, Feindel CM, et al. Reimplantation of the aortic valve at 20 years. J Thorac Cardiovasc Surg. 2016. PMID: 27923487. doi:10.1016/j.jtcvs.2016.10.081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。